CAMBRIDGE, Mass., Aug. 2 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) will webcast its corporate
presentation at the 26th Annual Canaccord Adams Summer Seminar. John Alam,
M.D., Executive Vice President, Medicines Development and Chief Medical
Officer of Vertex, will deliver the presentation on Tuesday, August 8, 2006
at 8:30 a.m. EDT.
The presentation will be webcast live and may be accessed by visiting
the Vertex website at http://www.vrtx.com. A replay of the webcast will
also be available on the Company's website until August 22, 2006. To access
the webcast, go to Vertex's website and select the 'Canaccord Adams 2006
Summer Seminar.' To ensure a timely connection, it is recommended that
users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. In collaboration
with GlaxoSmithKline, Vertex co-discovered the HIV protease inhibitor,
Lexiva.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
http://www.prnewswire.com/comp/938395.html /
CONTACT:
Lora Pike, Manager, Investor Relations, of
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
